DYSPNOEA and Flagyl

PatientsVille

DYSPNOEA Symptoms and Causes

When you're short of breath, it's hard or uncomfortable for you to take in the oxygen your body needs. You may feel as if you're not getting enough air. Sometimes you can have mild breathing problems because of a stuffy nose or intense exercise. But shortness of breath can also be a sign of a serious disease.

Many conditions can make you feel short of breath:

Lung conditions such as asthma, emphysema, or pneumonia
Problems with your trachea or bronchi, which are part of your airway system
Heart disease can make you feel breathless if your heart cannot pump enough blood to supply oxygen to your body
Anxiety and panic attacks
Allergies

If you often have trouble breathing, it is important to find out the cause.

Check out the latest treatments for DYSPNOEA

➢ DYSPNOEA treatment research studies

➢ Flagyl clinical trials, surveys and public health registries

Find Drug Side Effect reports

Flagyl Side Effects

Diarrhoea (69)

Pyrexia (65)

Paraesthesia (59)

Vomiting (56)

Nausea (53)

Dizziness (51)

Hypoaesthesia (46)

Rash (44)

Pain (44)

Neuropathy Peripheral (43)

Abdominal Pain (43)

Confusional State (41)

Pruritus (37)

Dyspnoea (37)

Weight Decreased (36)

Urticaria (36)

Chills (34)

Thrombocytopenia (32)

Dysgeusia (31)

Headache (29)

Hypersensitivity (29)

Renal Failure Acute (27)

Anxiety (27)

Erythema (26)

Convulsion (26)

Oedema Peripheral (23)

Insomnia (22)

Neutropenia (22)

Asthenia (22)

Cholestasis (22)

Malaise (21)

Fatigue (21)

Anaemia (20)

Burning Sensation (19)

Fall (18)

Gait Disturbance (18)

Arthralgia (18)

Alanine Aminotransferase Increased (17)

Clostridium Difficile Colitis (17)

Abdominal Discomfort (17)

Depression (17)

Toxic Skin Eruption (17)

Muscle Spasms (17)

Hepatitis (16)

Hypotension (16)

Pancreatitis Acute (16)

Pain In Extremity (16)

Tremor (16)

Pancreatitis (15)

Polyneuropathy (15)

➢ More

Common Meds

Abilify (10132)

Adderall (1304)

Amlodipine (6664)

Amoxicillin (4387)

Benadryl (1568)

Celebrex (12876 )

Celexa (1342)

Cialis (2975)

Cipro (8580)

Citalopram (7792)

Crestor (18839)

Cymbalta (14373)

Doxycycline (1757)

Effexor (7289)

Flexeril (435)

Flomax (2177)

Fluoxetine (4261)

Gabapentin (4593)

Hydrocodone (2469)

Ibuprofen (8222)

Lantus (10968)

Lexapro (3499)

Lipitor (17769)

Lisinopril (8919)

Lyrica (27148)

Medrol (650)

Mirena (41254)

Mobic (957)

Morphine (5356)

Naproxen (538)

Neurontin (6501)

Oxycodone (4438)

Pradaxa (13372)

Prednisone (5926)

Prilosec (2631)

Prozac (1954)

Seroquel (27216)

Simvastatin (8348)

Synthroid (4452)

Tamiflu (5585)

Topamax (3748)

Tramadol (5054)

Trazodone (1458)

Viagra (5394)

Vicodin (1153)

Wellbutrin (6324)

Xanax (2847)

Zocor (5718)

Zoloft(6792)

Zyrtec(1669)

Recent Reviews

I am currenty on Flagyl for a pelvic infection in combination with vibramyacin. This morning I took the vibramyacin and then was planning on taking the Flagyl an hour later, but I spent the this morning vomiting. I called the dr.

I took flagyl for 5 days each day feeling worse nausea an inner agitation and yawning for air difficulty breathing.....felt like it was attacking my intestines and the body was reacting and going into flight or fight. Very uncomfortable really unbear

My son was treated with flagyl and vancomycin for cdiff. Today after 2 weeks off vanco he has mucus in his stool. Does he still have cdiff? What should we do

The exact same thing happened to me after I was prescribed high dose flagyl for 5 days for suspected diverticulitis (painful bloating, frothy yellow diarrhea, excessive foul gas, etc.) my doc also put me on a Clear Liquid Diet for 3 days before I h

<span style='font-weight: bold;'><a href='http://sideeffects101.com/drug-side-effects/lumigan-cardiac-disorder.htm' rel='nofollow'>cardiac disorder</a>, <a href='http://sideeffects101.com/drug-side-effects/lumigan-dyspnoea.htm' r

Inadequate control of blood sugar, have to starve myself to get lower blood sugar even on two types of insulin, diarrhoea, dizziness, syncope, dyspnoea, severe malaise, nausea, tremors.

DYSPNOEA Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.

Rank

Status

Study

Recruiting

Improving Management of Breathlessness in Patients With Lung Cancer

Conditions:	Breathlessness; Dyspnea; Lung Cancer
Intervention:	Behavioral: Cognitive Behavioral Intervention for Breathlessness
Outcome Measures:	Feasibility and acceptability of a nurse practitioner-delivered dyspnea management intervention in patients with advanced lung cancer; Effect of a nurse practitioner-delivered dyspnea management intervention on breathlessness in patients with advanced lung cancer; Effect of a nurse practitioner-delivered dyspnea management intervention on quality of life in patients with advanced lung cancer; Effect of a nurse practitioner-delivered dyspnea management intervention on mood symptoms in patients with advanced lung cancer

Unknown ^†

Trial of a Breathlessness Intervention Service for Intractable Breathlessness

Condition:	Dyspnea
Interventions:	Behavioral: Breathlessness Intervention Service; Behavioral: Best supportive care (Standard Care)
Outcome Measures:	Numerical rating Scale (NRS) for distress due to breathlessness; Modified BORG; NRS Breathlessness at best/worst; Dyspnoea descriptors; CRQ; EQ-5D; HADS; CSRI; Charlson Co-morbidity score; Social Functioning; Karnofsky; Experience of breathlessness and expectations/views of BIS; Burden interview and caregiver Appr scale

Recruiting

Mechanisms of Exertional Dyspnea in Fibrotic Interstitial Lung Disease

Conditions:	Lung; Disease, Interstitial, With Fibrosis; Healthy
Interventions:	Other: Room air (21% oxygen); Other: Hyperoxia (60% oxygen)
Outcome Measures:	To determine the physiological mechanisms of exertional dyspnea in patients with fibrotic ILD; To determine the mechanism by which hyperoxia improves exertional dyspnea and exercise time; To determine any physiological mechanistic differences of exertional dyspnea between participants with fibrotic ILD and healthy control participants.

Recruiting

Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis

Conditions:	Lung; Disease; Cystic Fibrosis; Healthy
Intervention:
Outcome Measures:	To determine if dyspnea is qualitatively and quantitatively different in patients with cystic fibrosis compared with age and sex-matched healthy controls during exercise; To determine if the dyspnea responses can be explained by differences in the ventilatory response to exercise.

Unknown ^†

Vibration Response Imaging (VRI) in Dyspnea Patients Presenting to the ED

Condition:	Dyspnea
Intervention:
Outcome Measures:	Assess the ability of the VRI to improve clinical outcomes via accurate, early classification of the cause of acute dyspnea as HF or other (i.e. COPD, PE etc).; Assess the agreement to aid in classifying the cause of acute dyspnea as HF or other of the VRI in comparison to BNP/NTproBNP assays.; Assess the ability of the VRI to aid in classifying the cause of acute dyspnea as HF or COPD; Evaluate the ability of the VRI to monitor changes in clinical status following treatment in comparison with other standard testing methods (e.g. ECG, serial chest x-rays, etc.)

Recruiting

Prehospital Triage of Patients With Severe Shortness of Breath Using Biomarkers

Condition:	Dyspnea
Intervention:	Other: Supplementary NT-proBNP measurement
Outcome Measures:	Proportion of patients with dyspnea caused by heart disease initially triaged to department of cardiology; Proportion of patients with dyspnea of other etiologies initially triaged to department of cardiology; Proportion of patients with dyspnea caused by heart disease that receives pulmonary medication; Length of hospital stay; Intensive care unit admission rate; All-cause re-admission; Proportion of patients not admitted to hospital; All-cause mortality; Proportion of patients with dyspnea caused by lung disease, that receives traditional heart failure medication; Proportion of patients with correct diagnosis of congestive heart failure in the prehospital setting; Proportion of patients where congestive heart failure is correctly disproved in the prehospital setting

Recruiting

Self-Management Intervention for Breathlessness in Lung Cancer

Conditions:	Lung Cancer; Breathlessness
Intervention:	Behavioral: Self-management Intervention
Outcome Measures:	Perceived severity of breathlessness; Affective distress of breathlessness; Dyspnea with activities of daily living and exercise; Self-efficacy and mastery for managing breathlessness; Beliefs about breathlessness; Adherence and Use of Self-Management Strategies; Exercise capacity; Psychological distress; Quality of life; Health care utilization

Recruiting

Aerosol Inhalation Treatment for Dyspnea

Conditions:	Healthy; Dyspnea
Intervention:	Drug: Furosemide
Outcome Measures:	Subject rating of Breathing Discomfort (dyspnea); Multidimensional Dyspnea Profile; Urine output

Recruiting

Sensitivity of the Step Test to Detect Improvement in Dyspnea Following Bronchodilation in Patients With Chronic Obstructive Pulmonary Disease

Conditions:	Moderate Chronic Obstructive Pulmonary Disease; Severe Chronic Obstructive Pulmonary Disease; Dyspnea
Intervention:	Drug: Combination ipratropium/salbutamol or placebo (nebulization)
Outcome Measures:	Symptom perception; Cardiac and ventilatory outcomes; Inspiratory capacity; Respiratory pressures and diaphragm EMG; Pulmonary function; Maximal oxygen consumption; Maximal inspiratory pressure (PImax)

Not yet recruiting

Understanding the Importance of Plasticity in the Brain Mechanisms of Dyspnoea Perception

Condition:	Chronic Obstructive Pulmonary Disease
Interventions:	Drug: d-cycloserine; Drug: placebo
Outcome Measures:	BOLD signal changes; Grey matter volume

Unknown ^†

The Use of a Handheld Fan to Manage Breathlessness - A Feasibility Study

Condition:	Dyspnea
Intervention:	Device: handheld fan directed to cheeks
Outcome Measures:	Primary outcome measure is time in minutes for which breathlessness is improved after 5 minutes use of the fan directed at the face; Relief from breathlessness noted on relief score after using the handheld fan; Correlation between VAS and NRS scales

Recruiting

Acupuncture Feasibility Trial for Dyspnea in Lung Cancer

Conditions:	Lung Cancer; Dyspnea
Intervention:	Procedure: Acupuncture
Outcome Measure:	Dyspnea

Recruiting

Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer

Conditions:	NSCLC; Dyspnea
Interventions:	Drug: Tiotropium; Drug: Placebo
Outcome Measures:	12 question Cancer Dyspnea Scale; 10 point Dyspnea numeric scale; 10 point Cough scale; Forced Expiratory Volume 1 second (L/s) and Forced Vital Capacity (L)

Recruiting

EUROpean Dyspnoea Survey in the EMergency Departments

Conditions:	Dyspnea; Emergencies
Intervention:
Outcome Measures:	All cause mortality; All cause rehospitalization

Recruiting

Registry of Patients With Acute Dyspnea in the Emergency Department

Conditions:	Dyspnea; Heart Failure; COPD
Intervention:
Outcome Measures:	all cause mortality; demographics and baseline characteristics; medical care processes; subjective and objective risk assessment

Recruiting

Basics in Acute Shortness of Breath EvaLuation (BASEL V) Study

Condition:	Dyspnea
Intervention:
Outcome Measures:	Diagnostic accuracy for the diagnosis of heart failure; Prognostic utility in patients with dyspnea

Not yet recruiting

Dyspnea in COPD: Relationship With Exacerbations Frequency

Condition:	Dyspnea
Interventions:	Procedure: Spirometry; Procedure: CO Exhaled breath; Procedure: P01; Procedure: FeNO
Outcome Measures:	The negative airway pressure generated during the ﬁrst 100 ms of an occluded inspiration, which is an estimation of the neuromuscular drive to breathe. (P01 ); Borg scale; Fractional exhaled nitric oxide (FeNO); Inspiratory capacity (IC); Ventilation at rest; CO exhaled test

Recruiting

Treatment of Dyspnea in Do-not-intubate Patients

Conditions:	Acute Respiratory Failure; Acute on Chronic Respiratory Failure; Dyspnea
Interventions:	Device: NIV; Device: CPAP; Device: Standard oxygen; Device: HFNC
Outcome Measures:	Prevalence of use of Noninvasive ventilation in DNI patients; Subjects' comfort; Dyspnea score; Family members' impressions; Family member's impressions

Not yet recruiting

Inhaled Furosemide & Dyspnea

Condition:	Dyspnea
Interventions:	Other: CWS; Drug: Furosemide; Drug: Placebo
Outcome Measure:	Sensory intensity (Borg 0-10 scale) ratings of dyspnea at isotime

Recruiting

Inhaled Ondansetron & Dyspnea

Condition:	Dyspnea
Interventions:	Drug: Ondansetron; Other: CWS; Drug: Placebo
Outcome Measure:	Sensory Intensity (Borg 0-10 scale) ratings of dyspnea at isotime